Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230

20 May 2016

Abstract excerpt

// Christina Blackwell 1, * , Christian Sherk 1, * , Maggie Fricko 1, * , Gopinath Ganji 1 , Mary Barnette 1 , Bao Hoang 2 , James Tunstead 2 , Tina Skedzielewski 2 , Hasan Alsaid 2 , Beat M. Jucker 2 , Elisabeth Minthorn 1 , Rakesh Kumar 1 , M. Phillip DeYoung 1 1 Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA 2 Platform Technology and Science, GlaxoSmithKline Research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Fibroblast Growth Factor Research
Share to Occupational and environmental lung diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27223434
DOI: 10.18632/oncotarget.9515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230PMID 27223434Read ↗

Molecular Targeting of the Fibroblast Growth Factor Receptor (FGFR) Pathway Across Various CancersSemantic proximity Read ↗

The role of the HGF/Met axis in mesothelioma.Semantic proximity Read ↗

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesotheliomaSemantic proximity Read ↗

Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.Semantic proximity Read ↗

Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.Semantic proximity Read ↗

Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and BehaviorSemantic proximity Read ↗

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.Semantic proximity Read ↗

Autotaxin signaling governs phenotypic heterogeneity in visceral and parietal mesothelia.Semantic proximity Read ↗

FAK signaling in human cancer as a target for therapeuticsSemantic proximity Read ↗

Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferationSemantic proximity Read ↗

Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic StrategySemantic proximity Read ↗

Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.